The Unfolded Protein Response in Sterol Cytotoxicity

甾醇细胞毒性中未折叠的蛋白质反应

基本信息

  • 批准号:
    6719926
  • 负责人:
  • 金额:
    $ 40.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-12-01 至 2007-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The responses of cells to high levels of sterols has important implications for disease processes and normal physiology. In one setting, the accumulation of free cholesterol (FC) by atheroma macrophages (Mfs) leads to Mf death, which likely promotes plaque instability and acute clinical events, like myocardial infarction. In another setting, intestinal epithelial cells (IECs) are exposed to high levels of potentially toxic dietary and biliary cholesterol and dietary plant sterols, and so mechanisms are necessary to prevent intestinal dysfunction. The PI has recently discovered that a complex signal transduction pathway in the endoplasmic reticulum (ER)--the Unfolded Protein Response (UPR)--plays a critical role in the response of cultured Mrs to FC. The UPR first triggers a set of adaptive response, but then induces apoptosis if the adaptive responses fail. As such, the UPR initially promotes survival in FC-Ioaded Mfs, but then promotes apoptosis after prolonged FC loading. Because a unique branch of the UPR is localized to the gastrointestinal tract, and because a critical enzyme that protects IECs from sterol cytotoxicity is induced by the UPR, the UPR may also play an important role in the protection of IECs from high levels of sterols. In this context, the overall objective of this proposal is to investigate the roles and mechanisms of the UPR in adaptive and pathophysiological processes associated with the accumulation of excess sterols by atheroma Mfs and IECs. This objective will be met by: (a) determining if null mutations in two key UPR genes--one involved in the adaptive response and the other in apoptosis--affect lesional Mf death and plaque instability in the apoE-/- mouse model of atherosclerosis; (b) determining if the UPR is induced in IECs of mice exposed to excess dietary and plant sterols; if proteins known to help protect IECs from sterols are induced by the UPR; and if disruption of the UPR leads to intestinal dysfunction; and (c) investigating how FC induces the UPR by testing the hypothesis that FC enrichment of the ER membrane depletes ER calcium, which is a well-known and potent inducer of the UPR, by inhibiting the sarco/endoplasmic reticulum calcium ATPase or by activating ER calcium channels. The Mf studies will add to our understanding of how plaques become vulnerable and will suggest novel therapeutic targets involved in acute vascular events, and the intestinal studies will reveal a new and important aspect of intestinal-sterol physiology.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ira A Tabas其他文献

Ira A Tabas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ira A Tabas', 18)}}的其他基金

A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
一项将分辨率受损、胞吞作用缺陷和克隆造血与临床危险动脉粥样硬化斑块形成联系起来的机制和转化研究项目
  • 批准号:
    9889165
  • 财政年份:
    2019
  • 资助金额:
    $ 40.88万
  • 项目类别:
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
一项将分辨率受损、胞吞作用缺陷和克隆造血与临床危险动脉粥样硬化斑块形成联系起来的机制和转化研究项目
  • 批准号:
    10339421
  • 财政年份:
    2019
  • 资助金额:
    $ 40.88万
  • 项目类别:
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
一项将分辨率受损、胞吞作用缺陷和克隆造血与临床危险动脉粥样硬化斑块形成联系起来的机制和转化研究项目
  • 批准号:
    10565956
  • 财政年份:
    2019
  • 资助金额:
    $ 40.88万
  • 项目类别:
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
一项将分辨率受损、胞吞作用缺陷和克隆造血与临床危险动脉粥样硬化斑块形成联系起来的机制和转化研究项目
  • 批准号:
    10112953
  • 财政年份:
    2019
  • 资助金额:
    $ 40.88万
  • 项目类别:
"MerTK Cleavage and Signaling in Atherosclerosis"
“动脉粥样硬化中的 MerTK 裂解和信号转导”
  • 批准号:
    9120607
  • 财政年份:
    2016
  • 资助金额:
    $ 40.88万
  • 项目类别:
Autophagy in Advanced Atherosclerosis
晚期动脉粥样硬化中的自噬
  • 批准号:
    8023974
  • 财政年份:
    2011
  • 资助金额:
    $ 40.88万
  • 项目类别:
Autophagy in Advanced Atherosclerosis
晚期动脉粥样硬化中的自噬
  • 批准号:
    8383465
  • 财政年份:
    2011
  • 资助金额:
    $ 40.88万
  • 项目类别:
Autophagy in Advanced Atherosclerosis
晚期动脉粥样硬化中的自噬
  • 批准号:
    8575545
  • 财政年份:
    2011
  • 资助金额:
    $ 40.88万
  • 项目类别:
Autophagy in Advanced Atherosclerosis
晚期动脉粥样硬化中的自噬
  • 批准号:
    8208979
  • 财政年份:
    2011
  • 资助金额:
    $ 40.88万
  • 项目类别:
Mechanisms of Defective Efferocytosis in Atherosclerosis
动脉粥样硬化中细胞作用缺陷的机制
  • 批准号:
    8389888
  • 财政年份:
    2011
  • 资助金额:
    $ 40.88万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 批准年份:
    2019
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
姜黄素与TRAIL的协同抗肿瘤机制研究
  • 批准号:
    31101223
  • 批准年份:
    2011
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
  • 批准号:
    81100502
  • 批准年份:
    2011
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Complement Protein C1q Regulation of Macrophage Metabolic Pathways
补体蛋白 C1q 对巨噬细胞代谢途径的调节
  • 批准号:
    10629550
  • 财政年份:
    2023
  • 资助金额:
    $ 40.88万
  • 项目类别:
Innate Immune Response in Cardiac Healing and Rejuvenation
心脏愈合和恢复活力中的先天免疫反应
  • 批准号:
    10625955
  • 财政年份:
    2023
  • 资助金额:
    $ 40.88万
  • 项目类别:
lncRNA Function and Mechanisms during Cardiac Development and Disease
心脏发育和疾病过程中lncRNA的功能和机制
  • 批准号:
    10608600
  • 财政年份:
    2023
  • 资助金额:
    $ 40.88万
  • 项目类别:
Cell therapy regulates cardiac healing through innate immune response
细胞疗法通过先天免疫反应调节心脏愈合
  • 批准号:
    10561163
  • 财政年份:
    2023
  • 资助金额:
    $ 40.88万
  • 项目类别:
Biomimetic Vascular Matrix for Vascular Smooth Muscle Cell Mechanobiology and Pathology
用于血管平滑肌细胞力学生物学和病理学的仿生血管基质
  • 批准号:
    10586599
  • 财政年份:
    2023
  • 资助金额:
    $ 40.88万
  • 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
  • 批准号:
    10619831
  • 财政年份:
    2023
  • 资助金额:
    $ 40.88万
  • 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
  • 批准号:
    10589484
  • 财政年份:
    2023
  • 资助金额:
    $ 40.88万
  • 项目类别:
PET Tracer for Imaging of Lung Inflammation
用于肺部炎症成像的 PET 示踪剂
  • 批准号:
    10682270
  • 财政年份:
    2023
  • 资助金额:
    $ 40.88万
  • 项目类别:
Targeting the hepatic adropin signaling pathway in obesity
靶向肥胖中的肝脏 adropin 信号通路
  • 批准号:
    10677279
  • 财政年份:
    2023
  • 资助金额:
    $ 40.88万
  • 项目类别:
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
以前列腺癌为模型的强化降胆固醇干预和抗肿瘤免疫
  • 批准号:
    10802975
  • 财政年份:
    2023
  • 资助金额:
    $ 40.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了